Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

SHE:002424 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	395.63	417.94	605.02	465.63	1,031
Cash & Short-Term Investments	395.63	417.94	605.02	465.63	1,031
Cash Growth	-5.34%	-30.92%	29.94%	-54.84%	-9.32%
Accounts Receivable	1,954	2,202	2,207	1,981	2,100
Other Receivables	70.57	159.95	152.98	196.89	558.1
Receivables	2,024	2,362	2,360	2,178	2,659
Inventory	1,111	1,164	804.83	825.13	783.54
Other Current Assets	112.43	70.2	49.71	34.92	122.03
Total Current Assets	3,644	4,014	3,820	3,503	4,595
Property, Plant & Equipment	1,372	1,188	1,063	963.73	682.74
Long-Term Investments	994.13	1,442	1,447	1,473	1,339
Goodwill	21.38	21.38	20.58	20.58	20.58
Other Intangible Assets	208.48	197.25	205.1	214.86	133.39
Long-Term Deferred Tax Assets	230.76	192.2	82.67	66.84	46.89
Long-Term Deferred Charges	214.98	182.04	147.05	149.18	154.85
Other Long-Term Assets	449.18	112.16	108.97	82.17	60.59
Total Assets	7,135	7,349	6,894	6,474	7,033
Accounts Payable	782.95	904.77	581.28	403.88	558.35
Accrued Expenses	37.64	862.36	328.03	98.38	69.63
Short-Term Debt	1,432	1,436	1,481	1,448	2,063
Current Portion of Long-Term Debt	-	0.5	-	201.5	-
Current Portion of Leases	-	10.57	12.15	8.35	-
Current Income Taxes Payable	56.61	8.4	13.99	16.94	27.25
Current Unearned Revenue	75.58	92.75	155.91	46.17	68.82
Other Current Liabilities	1,415	201.19	196.46	199.32	75.98
Total Current Liabilities	3,800	3,517	2,768	2,422	2,863
Long-Term Debt	49.06	199.78	-	-	203.87
Long-Term Leases	21.95	39.46	74.53	57.66	-
Long-Term Unearned Revenue	61.29	34.96	22.38	23.4	23.95
Long-Term Deferred Tax Liabilities	3.6	31.08	33.04	28.81	21.72
Other Long-Term Liabilities	-	-	-	64.68	-
Total Liabilities	3,936	3,822	2,898	2,597	3,113
Common Stock	1,398	1,411	1,411	1,411	1,411
Additional Paid-In Capital	87.45	174.04	140.96	159.35	135.92
Retained Earnings	1,916	2,127	2,542	2,404	2,347
Treasury Stock	-219.59	-200.21	-100.2	-100.2	-
Comprehensive Income & Other	0.03	0.07	0.05	0.08	0.08
Total Common Equity	3,181	3,512	3,994	3,875	3,894
Minority Interest	18.04	14.89	2.27	2.29	26.42
Shareholders' Equity	3,199	3,527	3,996	3,877	3,920
Total Liabilities & Equity	7,135	7,349	6,894	6,474	7,033
Total Debt	1,503	1,686	1,567	1,715	2,267
Net Cash (Debt)	-1,108	-1,268	-962.25	-1,249	-1,236
Net Cash Per Share	-0.66	-0.92	-0.69	-0.84	-0.89
Filing Date Shares Outstanding	2,314	1,386	1,398	1,398	1,411
Total Common Shares Outstanding	2,314	1,386	1,398	1,398	1,411
Working Capital	-156.19	497.49	1,051	1,081	1,732
Book Value Per Share	1.37	2.54	2.86	2.77	2.76
Tangible Book Value	2,951	3,294	3,768	3,639	3,740
Tangible Book Value Per Share	1.28	2.38	2.70	2.60	2.65
Buildings	-	749.31	747.37	749.65	562.11
Machinery	-	906.73	757.09	672.55	642.37
Construction In Progress	-	258.07	182.45	77.92	15.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.